List view / Grid view
6 June 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has updated the US prescribing information for Pradaxa®...
21 May 2012 | By Merck
The U.S. FDA approved a labeling update for ISENTRESS® Film-coated Tablets to include 156-week data from the STARTMRK study...
15 May 2012 | By Bristol-Myers Squibb Company
State-of the art Manufacturing Facility Supports Company’s Growing Focus on Biologics...
11 May 2012 | By GlaxoSmithKline
The FDA has approved the New Drug Application for Fabior (tazarotene) Foam...
10 May 2012 | By Gilead Sciences
Vote to support approval of once-daily oral Truvada®...
9 May 2012 | By Pfizer
“We are pleased with the Committee’s positive evaluation..."
3 May 2012 | By Sanofi
FDA and the EMA approve 2nd operation for filling and finishing product...
1 May 2012 | By Pfizer
The U.S. FDA has approved ELELYSO™...
26 April 2012 | By Novartis
The FDA has approved Afinitor® tablets...
26 April 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved Votrient® (pazopanib)...
26 April 2012 | By Amgen
The FDA cannot approve the application in its present form...
20 April 2012 | By Sanofi
Full CARE-MS II results for Alemtuzumab to be unveiled...
20 April 2012 | By Abbott
Abbott has received U.S. FDA clearance to use its iFS Advanced Femtosecond Laser...
6 April 2012 | By Eli Lilly and Company
Amyvid is the first and only radioactive diagnostic agent approved for PET imaging of beta-amyloid neuritic plaques in the living brain...
5 April 2012 | By Teva Pharmaceutical Industries Ltd
Teva Pharmaceuticals USA, is sole first-to-file for both Orange Book patents listed for Provigil® (modafinil)...
